HCW Biologics (HCWB) Net Margin (2022 - 2025)
Historic Net Margin for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to 29183.24%.
- HCW Biologics' Net Margin fell 282681200.0% to 29183.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 5275.84%, marking a year-over-year decrease of 42048100.0%. This contributed to the annual value of 1173.09% for FY2024, which is 2581700.0% down from last year.
- Per HCW Biologics' latest filing, its Net Margin stood at 29183.24% for Q3 2025, which was down 282681200.0% from 184450.82% recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Net Margin ranged from a high of 65.99% in Q1 2022 and a low of 184450.82% during Q2 2025
- For the 4-year period, HCW Biologics' Net Margin averaged around 18605.52%, with its median value being 813.2% (2023).
- Per our database at Business Quant, HCW Biologics' Net Margin surged by 123569200bps in 2024 and then crashed by -1819817100bps in 2025.
- Over the past 4 years, HCW Biologics' Net Margin (Quarter) stood at 429.49% in 2022, then crashed by -89bps to 813.2% in 2023, then decreased by -6bps to 863.18% in 2024, then crashed by -3281bps to 29183.24% in 2025.
- Its last three reported values are 29183.24% in Q3 2025, 184450.82% for Q2 2025, and 43862.27% during Q1 2025.